Clinical Research

Pedigree analysis and prenatal diagnosis in a family with congenital ectopia lentis

  • Guixian PAN ,
  • Sitao LI ,
  • Hu HAO ,
  • Wei LIU ,
  • Qiuping YANG ,
  • Xin XIAO ,
  • Yao. CAI
Expand
  • Department of Pediatrics,the Sixth Affiliated Hospital,Sun Yat?sen University,Guangzhou 510655,Guangdong,China

Received date: 2025-01-13

  Online published: 2025-03-31

Abstract

Objective To analyze the clinical characteristics associated with prenatal diagnosis of FBN 1 gene mutations in a family. This study explores the correlation between gene mutations and their corresponding clinical phenotypes, emphasizing the significance of prenatal diagnosis in providing a foundation for subsequent follow?up and intervention. Methods Genomic DNA was extracted from the amniotic fluid of the fetus and the peripheral blood of the parents for trio?whole exome sequencing. The candidate variant identified was subsequently validated using Sanger sequencing. Results The pedigree comprised four generations and nine family members, with four individuals exhibiting slender limbs and toes. Among these, three showed congenital lens dislocation or subluxation. No abnormalities in the cardiovascular system were observed. Genetic testing of symptomatic individuals revealed a heterozygous mutation (c.6158G > T) in the FBN 1 gene. Conclusions The FBN 1 c.6158G > T (p.C2053F) mutation was identified as the pathogenic variant responsible for the condition in this family, exhibiting autosomal dominant inheritance. To our knowledge, this is the first reported case of the FBN 1 c.6158G > T (p.C2053F) mutation in China. Prenatal diagnosis can facilitate early confirmation of the condition and provide a foundation for subsequent interventions and follow?up care.

Cite this article

Guixian PAN , Sitao LI , Hu HAO , Wei LIU , Qiuping YANG , Xin XIAO , Yao. CAI . Pedigree analysis and prenatal diagnosis in a family with congenital ectopia lentis[J]. The Journal of Practical Medicine, 2025 , 41(6) : 824 -828 . DOI: 10.3969/j.issn.1006-5725.2025.06.008

References

1 STEPHENSON K, DOCKERY A, O'KEEFE M, et al. A FBN1 variant manifesting as non-syndromic ectopia lentis with retinal detachment: Clinical and genetic characteristics[J]. Eye (Lond), 2020,34(4):690-694. doi:10.1038/s41433-019-0580-2
2 SAKAI L Y, KEENE D R. Fibrillin protein pleiotropy: Acromelic dysplasias[J]. Matrix Biol,2019,80:6-13. doi:10.1016/j.matbio.2018.09.005
3 HALLER S J, ROITBERG A E, DUDLEY A T. Steered molecular dynamic simulations reveal Marfan syndrome mutations disrupt fibrillin-1 cbEGF domain mechanosensitive calcium binding[J]. Sci Rep, 2020,10(1):16844. doi:10.1038/s41598-020-73969-2
4 KAUR K, GURNANI B. Ectopia lentis[M]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing,2023: 35201721. doi:10.1080/15424065.2024.2389325
5 LIU X, NIU L, ZHANG L, et al. Clinical and genetic findings in Chinese families with congenital ectopia lentis[J]. Mol Genet Genomic Med, 2023,11(5):e2140. doi:10.1002/mgg3.2140
6 GUO D, LI S, XIAO X, et al. Clinical and Genetic Landscape of Ectopia Lentis Based on a Cohort of Patients From 156 Families[J]. Invest Ophthalmol Vis Sci, 2024,65(1):20. doi:10.1167/iovs.65.1.20
7 LOEYS B L, DIETZ H C, BRAVERMAN A C, et al. The revised Ghent nosology for the Marfan syndrome[J]. J Med Genet, 2010,47(7):476-485. doi:10.1136/jmg.2009.072785
8 李宝珠,舒晓蓉,陈仁华,等. 马方综合征分子遗传学研究进展 [J]. 中国当代医药, 2016, 23 (12): 15-18.
9 DU Q, ZHANG D, ZHUANG Y, et al. The Molecular Genetics of Marfan Syndrome[J]. Int J Med Sci, 2021,18(13):2752-2766. doi:10.7150/ijms.60685
10 SCHRIJVER I, LIU W, BRENN T, et al. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: Distinct effects on biochemical and clinical phenotypes[J]. Am J Hum Genet, 1999,65(4):1007-1020. doi:10.1086/302582
11 FAIVRE L, COLLOD-BEROUD G, LOEYS B L, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: An international study[J]. Am J Hum Genet, 2007,81(3):454-466. doi:10.1086/520125
12 STHENEUR C, TUBACH F, JOUNEAUX M, et al. Study of phenotype evolution during childhood in Marfan syndrome to improve clinical recognition[J]. Genet Med, 2014,16(3):246-250. doi:10.1038/gim.2013.123
13 ERKULA G, JONES K B, SPONSELLER P D, et al. Growth and maturation in Marfan syndrome[J]. Am J Med Genet, 2002,109(2):100-115. doi:10.1002/ajmg.10312
14 FAIVRE L, MASUREL-PAULET A, COLLOD-BEROUD G, et al. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations[J]. Pediatrics, 2009,123(1):391-398. doi:10.1542/peds.2008-0703
15 刘思源,刘欣欣,叶倩,等. 先天性晶状体脱位的治疗及预后研究进展[J]. 眼科学报, 2024,39(8):424-430.
16 ESFANDIARI H, ANSARI S, MOHAMMAD-RABEI H, et al. Management Strategies of Ocular Abnormalities in Patients with Marfan Syndrome: Current Perspective[J]. J Ophthalmic Vis Res, 2019,14(1):71-77. doi:10.4103/jovr.jovr_29_18
17 TANG S Z, LIU Y N, HU S H, et al. Mutation analysis of FBN1 gene in two Chinese families with congenital ectopia lentis in northern China[J]. Int J Ophthalmol, 2019,12(11):1674-1679. doi:10.18240/ijo.2019.11.02
18 HARTON G L, TSIPOURAS P, SISSON M E, et al. Preimplantation genetic testing for Marfan syndrome[J]. Mol Hum Reprod. 1996,2(9):713-715. doi:10.1093/molehr/2.9.713
19 CHEN S, FEI H, ZHANG J, et al. Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations[J]. Front Mol Biosci, 2021,8:749842. doi:10.3389/fmolb.2021.749842
20 VLAHOS N F, TRIANTAFYLLIDOU O, VITORATOS N, et al. Preimplantation genetic diagnosis in marfan syndrome[J]. Case Rep Obstet Gynecol, 2013,2013:542961. doi:10.1155/2013/542961
21 WANG S, NIU Z, WANG H, et al. De Novo Paternal FBN1 Mutation Detected in Embryos Before Implantation[J]. Med Sci Monit, 2017,23:3136-3146. doi:10.12659/msm.904546
22 ZENG Y, LI J, LI G, et al. Correction of the Marfan Syndrome Pathogenic FBN1 Mutation by Base Editing in Human Cells and Heterozygous Embryos[J]. Mol Ther, 2018,26(11):2631-2637. doi:10.1016/j.ymthe.2018.08.007
Outlines

/